Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): A longitudinal study

Clinical Endocrinology

Volumn 64, Issue 4, 2006, Pages 375-383

  Madeddu, Giordano ^a   Spanu, Angela ^a   Chessa, Francesca ^a   Calia, Giovanna Maria ^a   Lovigu, Carla ^a   Solinas, Patrizia ^a   Mannazzu, Marco ^a   Falchi, Antonio ^a   Mura, Maria Stella ^a   Madeddu, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LIOTHYRONINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHYROIDISM; IMMUNORADIOMETRIC ASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THYROID FUNCTION; THYROID FUNCTION TEST;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HIV; HIV INFECTIONS; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; STAVUDINE; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 33644899685     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02472.x     Document Type: Article

References (75)

1. Hofbauer L.C. Heufelder A.E. 1996 Endocrine implications of human immunodeficiency virus infection Medicine 75 262 278
2. Grinspoon S.K. Bilezikian J.P. 1992 HIV disease and the endocrine system The New England Journal of Medicine 327 1360 1365
3. Grinspoon S.K. Donovan D.S. Jr. Bilezikian J.P. 1994 Aetiology and pathogenesis of hormonal and metabolic disorders in HIV infection Baillere's Clinical Endocrinology and Metabolism 8 735 755
4. Mylonakis E. Koutkia P. Grinspoon S. 2001 Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women Clinical Infectious Diseases 33 857 864
5. Lambert M. 1994 Thyroid dysfunction in HIV infection Bailleres Clinical Endocrinology and Metabolism 8 825 835
6. Tang W.W. Kaptein E.M. 1989 Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex The Western Journal of Medicine 151 627 631
7. Grunfeld C. Pang M. Doerrler W. Jensen P. Shimizu L. Feingold K.R. Cavalieri R.R. 1993 Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome Metabolism 42 1270 1276
8. Ricart-Engel W. Fernandez-Real J.M. Gonzalez-Huiz F. del Pozo M. Mascaro J. Garcia-Bragado F. 1996 The relation between thyroid function and nutritional status in HIV-infected patients Clinical Endocrinology 44 53 58
9. Welch K. Finkbeiner W. Alpers C.E. Blumenfeld W. Davis R.L. Smukler E.A. Beckstead J.H. 1984 Autopsy findings in the acquired immune deficiency syndrome Journal of American Medical Association 252 1152 1159
10. Battan R. Mariuz P. Raviglione M.C. Sabatini M.T. Mullen M.P. Poretsky L. 1991 Pneumocystis carinii infection of the thyroid in a hypothyroid patient with AIDS: diagnosis by fine needle aspiration biopsy The Journal of Clinical Endocrinology and Metabolism 72 724 726
11. Drucker D. Bailey D. Rotstein L. 1990 Thyroiditis as the presenting manifestation of disseminated extrapulmonary Pneumocystis carinii infection The Journal of Clinical Endocrinology and Metabolism 71 1663 1665
12. Mollison L.C. Mijch A. McBride G. Dwyer B. 1991 Hypothyroidism due to destruction of the thyroid by Kaposi's sarcoma Reviews of Infectious Diseases 13 826 827
13. Isley W.L. 1987 Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement 1-thyroxine Annals of Internal Medicine 107 517 518
14. Sato K. Satoh T. Shizume K. Ozawa M. Han D.C. Imamura H. Tsushima T. Demura H. Kanaji Y. Ito Y. 1990 Inhibition of 1251 organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture The Journal of Clinical Endocrinology and Metabolism 70 1735 1743
15. Meier C.A. Burger A.G. 2000 Effects of drugs and other substances of thyroid hormone synthesis and metabolism In Braverman L. Utiger R.D. Ed Werner and Ingbar's the Thyroid: a Fundamental and Clinical Text 8th edn Lippincott: Williams & Wilkins Philadelphia 265 295
16. Fentiman I.S. Thomas B.S. Balkwill F.R. Rubens R.D. Hayward J.L. 1985 Primary hypothyroidism associated with interferon therapy of breast cancer [Letter] Lancet 325 1166
17. Dobs A.S. Dempsy M.A. Ladenson P.W. Polk B.F. 1988 Endocrine disorders in men infected with the human immunodeficiency virus The American Journal of Medicine 84 611 616
18. Sellmeyer D.E. Grunfeld C. 1996 Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome Endocrine Reviews 17 518 527
19. Hommes M.J.T. Romijn J.A. Godfried M.H. Shattenkerk E. Buurman W.A. Endert E. Sauerwein H.P. 1990 Increased resting energy expenditure in human immunodeficiency virus-infected men Metabolism: Clinical and Experimental 39 1186 1190
20. Hommes M.J.T. Romijn J.A. Endert E. Adriaanse R. Brabant G. Shattenkerk E. Wiersinga W.M. Sauerwein H.P. 1993 Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection Metabolism: Clinical and Experimental 42 556 561
21. Fried J.C. LoPresti J.S. Micon M. Bauer M. Tuchschmidt J.A. Nicoloff J.T. 1990 Serum triiodothyronine values: prognostic indicators of acute mortality due to Pneumocystis carinii pneumonia associated with the acquired immunodeficiency syndrome Archives of Internal Medicine 150 406 409
22. Merenich J.A. McDermott M.T. Asp A.A. Harrison S.M. Kidd G.S. 1990 Evidence of endocrine involvement early in the course of human immunodeficiency virus infection The Journal of Clinical Endocrinology and Metabolism 70 566 570
23. Lambert M. Zech F. DeNayer P. Jamez J. Vandercam B. 1990 Elevation of serum thyroxine binding globulin (but not of cortisol binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection The American Journal of Medicine 89 748 751
24. Lo Presti J.S. Fried J.C. Spencer C.A. Nicoloff J.T. 1989 Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome Annals of Internal Medicine 110 970 975
25. Raffi F. Brisseau J.M. Planchon B. Remi J.P. Barrier J.H. Grolleau J.Y. 1991 Endocrine function in 98 HIV infected patients: a perspective study AIDS 5 729 733
26. 1-positive outpatients European Journal of Clinical Investigation 21 59 63
27. Eisenstein Z. Hagg S. Vagenakis A.G. Fang S.L. Ransil B. Burger A. Balsam A. Braverman L.E. Ingbar S.H. 1978 Effect of starvation on the production and peripheral metabolism of 3,3′,5′-triiodothyronine in euthyroid obese subjects The Journal of Clinical Endocrinology and Metabolism 47 889 893
28. Wartofsky L. Burman K.D. 1982 Alterations in thyroid function in patients with systemic illnesses: the euthyroid sick syndrome Endocrine Reviews 3 164 217
29. Grunfeld C. Kotler D.P. Shigenaga J.K. Doerrler W. Tierney A. Wang J. Pierson R.N. Feingold K.R. 1991 Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome The American Journal of Medicine 90 154 162
30. Grunfeld C. Pang M. Doerrler W. Shigenaga J.K. Jensen P. Feingold K.R. 1992 Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome The Journal of Clinical Endocrinology and Metabolism 74 1045 1052
31. Hellerstein M.K. Grunfeld C. Wu K. Chrstiansen M. Kaemfer S. Kletke C. Shackleton C.H. 1993 Increased de novo hepatic lipogenesis in human immunodeficency virus infection The Journal of Clinical Endocrinology and Metabolism 76 559 565
32. Brockmeyer N. Kreuter A. Bader A. Seemann U. Reimann G. 2000 Prevalence of endocrine dysfunction in HIV-infected men Hormone Research 54 294 295
33. Grappin M. Piroth L. Verges B. Sgro C. Mack G. Buisson M. Duong M. Chavanet P. Portier H. 2000 Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy AIDS 14 1070 1072
34. Esnault J.L. Billaud E. Milpied B. Bonnet B. Murat A. Leautez S. Raffi F. 2001 High prevalence of thyroid abnormalities in the era of highly active antiretroviral therapy Antiviral Therapy 6 12
35. Collazos J. Ibarra S. Mayo J. 2003 Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system AIDS 17 763 765
36. Calza L. Manfredi R. Chiodo F. 2002 Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 31 361 363
37. Madeddu G. Spanu A. Solinas P. Calia G.M. Lovigu C. Mannazzu M. Falchi A. Mura M.S. Madeddu G. 2002 Thyroid function in HIV patients treated with highly active antiretroviral therapy (HAART) World Journal of Nuclear Medicine 1 225
38. Beltran S. Lescure F.X. Desailloud R. Douadi Y. Smail A. El Esper I. Arlot S. Schmit J.L. 2003 and The thyroid and VIH (THYVI) group increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening Clinical Infectious Diseases 37 579 583
39. Quirino T. Bongiovanni M. Ricci E. Chebat E. Carradori S. Martinelli C. Valsecchi L. Landonio S. Bini T. Bonfanti P. 2004 Hypothyroidism in HIV-infected patients who have or have not received HAART Clinical Infectious Diseases 38 596
40. Madeddu G. Spanu A. Solinas P. Calia G.M. Lovigu C. Chessa F. Mannazzu M. Falchi A. Mura M.S. Madeddu G. 2004 A prospective study on thyroid function in HIV patients on highly active antiretroviral therapy (HAART) European Journal of Nuclear Medicine and Molecular Imaging 31 P657
41. Vigano A. Riboni S. Bianchi R. Cafarelli L. Vago T. Manzoni P. Di Natale B. 2004 Thyroid dysfunction in antiretroviral treated children The Pediatric Infectious Diseases Journal 23 235 239
42. Carr A. Samaras K. Burton S. Law M. Freund J. Chisholm D.J. Cooper D.A. 1998 A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 F51 F52
43. Carr A. Miller J. Law M. Cooper D.A. 2000 A syndrome of lipoatrophy, lactic acidemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome AIDS 14 25 32
44. Rietshel P. Corcoran C. Satnley T. Basgoz N. Klinbansky A. Grinspoon S. 2000 Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy Clinical Infectious Diseases 31 1240 1244
45. Saves M. Raffi F. Capeau J. Rozebaum W. Ragnaud J.M. Perronne C. Basdevant A. Leport C. Chene G. Antiproteases Cohorte (APROCO) Study Group 2002 Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clinical Infectious Diseases 34 1396 1405
46. Chene G. Angelini E. Cotte L. Lang J.M. Morlat P. Rancinan C. May T. Journot V. Raffi F. Jarrousse B. Grappin M. Lepeu G. Molina G.M. 2002 Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients Clinical Infectious Diseases 34 649 657
47. Tebas P. Powderly W.G. Claxton S. Marin D. Tantisirivar W. Teitelbaum S.L. Yarasheski K.E. 2000 Accelerated bone mineral loss in HIV-infected patients potent antiretroviral therapy AIDS 14 F63 F67
48. Moore A. Vashitht A. Sabin C.A. Mocroft A. Madge S. Philips A.N. Studd J.W. Johnson M.A. 2001 Reduced bone density in HIV-positive individuals AIDS 15 1731 1733
49. Madeddu G.R. Spanu A. Solinas P. Calia G.M. Lovigu C. Chessa F. Mannazzu M. Falchi A. Mura M.S. Madeddu G. 2004 Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy The Quarterly Journal of Nuclear Medicine and Molecular Imaging 48 39 48
50. Huang J.S. Rietschel P. Hadigna C.M. Rosenthal D.L. Grinspoon S. 2001 Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy AIDS 15 975 982
51. Mora S. Sala N. Bricalli D. Zuin G. Chiumello G. Vigano A. 2001 Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy AIDS 15 1823 1829
52. Carr A. Miller J. Eisman J.A. Cooper D.A. 2001 Osteopenia in HIV infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy AIDS 15 703 709
53. Aukrust P. Liabakk N.B. Müller F. Lien E. Espevik T. Frøland S.S. 1994 Serum levels of tumor necrosis factor (TNF) α and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters The Journal of Infectious Diseases 169 420 424
54. Serrano S. Marinoso M.L. Soriano J.C. Rubies-Prat J. Aubia J. Coll J. Bosch J. Del Rio L. Vila J. Goday A. Nacher M. 1995 Bone remodelling in human immunodeficiency virus-1 infected patients. A histomorphometric study Bone 16 185 191
55. Pacifici R. 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis Journal of Bone and Mineral Research 11 1043 1051
56. Poli V. Balena R. Fattori E. Markatos A. Yamamoto M. Tanaka H. Ciliberto G. Rodan G.A. Costantini F. 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion The EMBO Journal 13 1189 1196
57. Chen F. Day S.L. Metcalfe R.A. Sethi G. Kapembwa M.S. Brook M.G. Churchill D. de Ruiter A. Robinson S. Lacey C.J. Weetman A.P. 2005 Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease Medicine 84 98 106
58. Wong K.H. Chow W.S. Lee S.H. 2004 Clinical hyperthyroidism in Chinese patients with stable HIV disease Clinical Infectious Diseases 39 1257 1259
59. Ledru E. Christeff N. Patey O. de Truchis P. Melchior J.C. Gougeon M.L. 2000 Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome Blood 95 3191 3198
60. Dìez J. Hernanz A. Medina S. Bayon C. Iglesias P. 2002 Serum concentrations of tumor necrosis factor-alpha (TNF-α) and soluble TNF-α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function Clinical Endocrinology 57 515 521
61. Mauss S. Corzillius M. Wolf E. Schwenk A. Adam A. Jaeger H. Knechten H. Goelz J. Goetzenich A. DAGNA, Lipantiretroviral Therapy Study Group 2002 Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment HIV Medicine 3 49 55
62. Seminari E. Tinelli C. Minoli L. Sacchi P. Filice G. Zocchetti C. Meneghetti G. Bruno R. Maserati R. 2002 Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients Antiviral Therapy 7 175 180
63. Lichtenstein K.A. Delaney K.M. Armon C. Ward D.J. Moorman A.C. Wood K.C. Holmberg S.D. 2003 Incidence of and risk factor for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients Journal of Acquired Immune Deficiency Syndromes 32 48 56
64. Cozzolino M. Vidal M. Arcidiacono M.V. Tebas P. Yarasheski K.E. Dusso A.S. 2003 HIV protease inhibitor impair vitamin D bioactivation to 1,25-dihydroxyvitamin D AIDS 17 513 520
65. Cherry C.L. Gahan M.E. McArthur J.C. Lewin S.R. Hoy J.F. Wesseling S.L. 2002 Exposure to dideoxynucleosides is reflected a lowered mitochondrial DNA in subcutaneous fat Journal of Acquired Immune Deficiency Syndromes 30 271 277
66. Moore R.D. Wong W.E. Keruly J.C. McArthur J.C. 2000 Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea AIDS 14 273 278
67. Moore R.D. Keruly J.C. Chaisson R.E. 2001 Incidence of pancreatitis in HIV-infected patients on nucleoside RTIs 8th Conference on Retroviruses and Opportunistic Infections, Chicago, USA, 4-8 February; Abstract Book: abstract no. 620
68. John M. Moore C.B. James I.R. Nolan D. Upton R.P. McKinnon E.J. Mallal S.A. 2001 Chronic hyperlactaemia in HIV-infected patients taking antiretroviral therapy AIDS 15 717 723
69. Joly V. Flandre P. Meifreddy V. Leturque N. Harel M. Aboulker J.P. Yeni P. 2002 Increased risk of lipoatrophy under stavudine in HIV-1 infected patients: results of a substudy from a comparative trial AIDS 16 2447 2454
70. Saves M. Raffi F. Caveau J. Rozenbaum W. Ragnaud J.M. Perronne C. Basdevant A. Leport C. Chene G. Antiprotease Cohorte (APROCO) Study Group 2002 Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clinical Infectious Diseases 34 1396 1405
71. Galli M. Cozzi-Lepri A. Ridolfo A.L. Gervasoni C. Ravasio L. Corsico L. Gianelli E. Vaccarezza M. Vullo V. Cargnel A. Minoli L. Coronado O. Giacometti A. Antinori A. Antonucci G. D'Arminio Monforte A. Moroni M. Lipo I CoNa Study. ( 2002 Study incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa study Archives of Internal Medicine 162 2621 2628
72. Nolan D. Hammond E. Martin A. Taylor L. Herrmann S. Mckinnon E. Metcalf C. Latham B. Mallal S. 2003 Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy AIDS 17 1329 1338
73. Barbaro G. Klatt E.C. 2003 Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients Current Pharmaceutical Design 9 1475 1481
74. Barbaro G. 2005 Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy Current drug targetsCardiovascular and Haematological Disorders 5 337 343
75. Hak A.E. Pols H.A.P. Visser T.J. Drexhage H.A. Hofman A. Witteman J.C.M. 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study Annals of Internal Medicine 132 270 278